Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism.
Gynecol Endocrinol
; 30 Suppl 1: 22-4, 2014 Oct.
Article
in En
| MEDLINE
| ID: mdl-25200823
The prevalence of androgen deficiency in reproductive-aged men is increasing and needs new approach to long-term hypogonadism treatment that can preserve fertility. An open non-controlled pilot study included 18 men with eugonadotropic hypogonadism, who received transdermal testosterone gel treatment for 3 months. Sperm analysis was made before treatment and after 3 month of testosterone therapy. Testosterone level was normalized in all patients, but no negative effect was observed on spermatogenesis. Testosterone gel therapy may be a therapy of choice in hypogonadal men of reproductive age but further studies are needed.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Spermatogenesis
/
Testosterone
/
Hormone Replacement Therapy
/
Hypogonadism
Type of study:
Risk_factors_studies
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Gynecol Endocrinol
Journal subject:
ENDOCRINOLOGIA
/
GINECOLOGIA
Year:
2014
Type:
Article